A Multi-Disciplinary Technology-Based Care for Diabetic Ketoacidosis in Patients With Type 1 Diabetes
Stopped early · Not applicable
Conditions studied: Diabetic Ketoacidosis
In brief
The study team proposes that use of a novel multi-disciplinary approach with continuous glucose monitoring technology can significantly improve glycemic control and reduce readmissions among those with type 1 diabetes mellitus (T1DM) admitted for Diabetic ketoacidosis (DKA). This will also help promote a pathway for care of these patients after admission utilizing resources which are available within the Endocrinology, Diabetes and Metabolism department at the Cleveland Clinic.
Key facts
- Study ID
- NCT06471322
- Run by
- The Cleveland Clinic
- People needed
- 2
- Starts
- 2024-11-15
- Expected to finish
- 2025-11-01
- Last updated by the study team
- 2026-02-20
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age 18 years old or older
- Diagnosis of Type 1 Diabetes
- Admitted to the hospital with confirmed DKA as determined by emergency department or admitting team
- Compatible smart phone with the Libre 3
- Active insurance plan
You may not qualify if…
- Allergy to any component of the Libre 3
- Condition which, in investigator judgement would limit their ability to participate safely
Where it is running
- The Cleveland Clinic Foundation — Cleveland, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.